The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice

Morino, 2008, Muscle specific IRS-1 Ser->Ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle, Diabetes., 57, 2644, 10.2337/db06-0454 Danial, 2008, Dual role of proapoptotic BAD in insulin secretion and beta cell survival, Nat. Med., 14, 144, 10.1038/nm1717 Wellen, 2003, Obesity-induced inflammatory changes in adipose tissue, J. Clin. Invest., 112, 1785, 10.1172/JCI20514 Weisberg, 2006, CCR2 modulates inflammatory and metabolic effects of high-fat feeding, J. Clin. Invest., 116, 115, 10.1172/JCI24335 Eckel, 2004, Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: executive summary, Circulation., 110, 2968, 10.1161/01.CIR.0000140086.88453.9A Tounian, 2001, Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study, Lancet., 358, 1400, 10.1016/S0140-6736(01)06525-4 Osei-Hyiaman, 2005, Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity, J. Clin. Invest., 115, 1298, 10.1172/JCI200523057 Kruger, 2005, D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes, Circulation., 111, 3126, 10.1161/CIRCULATIONAHA.104.517102 Kruger, 2006, Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects, J. Pharmacol. Exp. Ther., 319, 1144, 10.1124/jpet.106.107482 Abraham, 2008, Pharmacological and clinical aspects of heme oxygenase, Pharmacol. Rev., 60, 79, 10.1124/pr.107.07104 Steinberg, 1996, Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance, J. Clin. Invest., 97, 2601, 10.1172/JCI118709 Yudkin, 2000, Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?, Atherosclerosis., 148, 209, 10.1016/S0021-9150(99)00463-3 Zhang, 2004, CO modulates pulmonary vascular response to acute hypoxia: relation to endothelin, Am. J. Physiol. Heart Circ. Physiol., 286, H137, 10.1152/ajpheart.00678.2002 Porstmann, 2005, PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP, Oncogene., 24, 6465, 10.1038/sj.onc.1208802 Lee, 2004, Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection, Circulation., 110, 1296, 10.1161/01.CIR.0000140694.67251.9C Navab, 2004, Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice, Circulation., 109, 3215, 10.1161/01.CIR.0000134275.90823.87 Navab, 2004, The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL, J. Lipid Res., 45, 993, 10.1194/jlr.R400001-JLR200 Navab, 2003, Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis, Curr. Opin. Investig. Drugs., 4, 1100 Buga, 2008, D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet, J. Lipid Res., 49, 192, 10.1194/jlr.M700433-JLR200 Ou, 2003, L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease, Circulation., 107, 2337, 10.1161/01.CIR.0000070589.61860.A9 Ou, 2003, L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells, Circulation., 107, 1520, 10.1161/01.CIR.0000061949.17174.B6 Peterson, 2007, Long-term treatment with the apolipoprotein A1 mimetic peptide increases antioxidants and vascular repair in type I diabetic rats, J. Pharmacol. Exp. Ther., 322, 514, 10.1124/jpet.107.119479 Peterson, 2008, L-4F treatment reduces adiposity, increases adiponectin levels and improves insulin sensitivity in obese mice, J. Lipid Res., 49, 1658, 10.1194/jlr.M800046-JLR200 L'Abbate, 2007, Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats, Am. J. Physiol. Heart Circ. Physiol., 293, H3532, 10.1152/ajpheart.00826.2007 Li, 2008, Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance, Diabetes., 57, 1526, 10.2337/db07-1764 Kim, 2008, Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines, tumor necrosis factor-alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells, J. Pharmacol. Exp. Ther., 325, 833, 10.1124/jpet.107.135285 Navab, 2002, Oral administration of an Apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol, Circulation., 105, 290, 10.1161/hc0302.103711 Hu, 2005, Phosphatidylinositol 3-kinase mediates angiogenesis and vascular permeability associated with ovarian carcinoma, Clin. Cancer Res., 11, 8208, 10.1158/1078-0432.CCR-05-0206 Hu, 2002, Inhibition of phosphatidylinositol 3′-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models, Cancer Res., 62, 1087 Salinas, 2003, Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner, J. Biol. Chem., 278, 13898, 10.1074/jbc.M209164200 Positano, 2004, An accurate and robust method for unsupervised assessment of abdominal fat by MRI, J. Magn. Reson. Imaging., 20, 684, 10.1002/jmri.20167 Demerath, 2007, Validity of a new automated software program for visceral adipose tissue estimation, Int. J. Obes. (Lond)., 31, 285, 10.1038/sj.ijo.0803409 Bonekamp, 2008, Quantitative comparison and evaluation of software packages for assessment of abdominal adipose tissue distribution by magnetic resonance imaging, Int. J. Obes. (Lond)., 32, 100, 10.1038/sj.ijo.0803696 Lee, 2004, Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue, Cell. Physiol. Biochem., 14, 311, 10.1159/000080341 Novikoff, 1980, Organelle relationships in cultured 3T3–L1 preadipocytes, J. Cell Biol., 87, 180, 10.1083/jcb.87.1.180 Tondreau, 2005, Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity, Stem Cells., 23, 1105, 10.1634/stemcells.2004-0330 Kim, 2007, Obesity-associated improvements in metabolic profile through expansion of adipose tissue, J. Clin. Invest., 117, 2621, 10.1172/JCI31021 Nicolai, 2009, Heme Oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats, Hypertension., 53, 508, 10.1161/HYPERTENSIONAHA.108.124701 Khan, 2009, Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI, Mol. Cell Biol., 29, 1575, 10.1128/MCB.01300-08 Williams, 2006, Effect of fat distribution on endothelial-dependent and endothelial-independent vasodilatation in healthy humans, Diabetes Obes. Metab., 8, 296, 10.1111/j.1463-1326.2005.00505.x Bastard, 2002, Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro, J. Clin. Endocrinol. Metab., 87, 2084, 10.1210/jcem.87.5.8450 Maachi, 2004, Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women, Int. J. Obes. Relat. Metab. Disord., 28, 993, 10.1038/sj.ijo.0802718 Hingorani, 2000, Acute systemic inflammation impairs endothelium-dependent dilatation in humans, Circulation., 102, 994, 10.1161/01.CIR.102.9.994 Muse, 2007, Hypothalamic resistin induces hepatic insulin resistance, J. Clin. Invest., 117, 1670, 10.1172/JCI30440 Lazar, 2005, How obesity causes diabetes: not a tall tale, Science., 307, 373, 10.1126/science.1104342 Kondo, 2002, Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome, Diabetes., 51, 2325, 10.2337/diabetes.51.7.2325 Fasshauer, 2001, Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3–L1 adipocytes, FEBS Lett., 507, 142, 10.1016/S0014-5793(01)02960-X Bahia, 2006, Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome, Clinics., 61, 433, 10.1590/S1807-59322006000500010 Han, 2007, Adiponectin and cardiovascular disease: response to therapeutic interventions, J. Am. Coll. Cardiol., 49, 531, 10.1016/j.jacc.2006.08.061 Fontana, 2007, Visceral fat adipokine secretion is associated with systemic inflammation in obese humans, Diabetes., 56, 1010, 10.2337/db06-1656 Iwashima, 2006, Adiponectin and inflammatory markers in peripheral arterial occlusive disease, Atherosclerosis., 188, 384, 10.1016/j.atherosclerosis.2005.10.039 Yamauchi, 2007, Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions, Nat. Med., 13, 332, 10.1038/nm1557 Kearney, 2008, Insulin resistance and endothelial cell dysfunction: studies in mammalian models, Exp. Physiol., 93, 158, 10.1113/expphysiol.2007.039172 Duncan, 2008, The effect of endothelium-specific insulin resistance on endothelial function in vivo, Diabetes., 57, 3307, 10.2337/db07-1111 Fleming, 2003, AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets, Thromb. Haemost., 90, 863, 10.1160/TH03-04-0228 Kovacic, 2003, Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart, J. Biol. Chem., 278, 39422, 10.1074/jbc.M305371200 Longnus, 2005, Insulin signalling downstream of protein kinase B is potentiated by 5′AMP-activated protein kinase in rat hearts in vivo, Diabetologia., 48, 2591, 10.1007/s00125-005-0016-3 Hardie, 2003, Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status, Endocrinology., 144, 5179, 10.1210/en.2003-0982 Hardie, 2007, AMP-activated protein kinase as a drug target, Annu. Rev. Pharmacol. Toxicol., 47, 185, 10.1146/annurev.pharmtox.47.120505.105304 Di Noia, 2006, Heme oxygenase-1 enhances renal mitochondrial transport carriers and cytochrome C oxidase activity in experimental diabetes, J. Biol. Chem., 281, 15687, 10.1074/jbc.M510595200 Ouchi, 2004, Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells, J. Biol. Chem., 279, 1304, 10.1074/jbc.M310389200 Sun, 2005, Microvascular patterning is controlled by fine-tuning the Akt signal, Proc. Natl. Acad. Sci. USA., 102, 128, 10.1073/pnas.0403198102 Schulz, 2008, Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction, Circulation., 118, 1347, 10.1161/CIRCULATIONAHA.108.784289 Chen, 2008, Regulation of ROS signal transduction by NADPH oxidase 4 localization, J. Cell Biol., 181, 1129, 10.1083/jcb.200709049 Murabito, 2008, Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: The Framingham Offspring Study, Atherosclerosis., 203, 509, 10.1016/j.atherosclerosis.2008.06.031